Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 4608

1.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
2.

Treatment and prevention of influenza: Swedish recommendations.

Uhnoo I, Linde A, Pauksens K, Lindberg A, Eriksson M, Norrby R; Swedish Consensus Group.

Scand J Infect Dis. 2003;35(1):3-11. Review.

PMID:
12685876
3.

Oseltamivir: new preparation. An antiviral agent with little impact on influenza.

[No authors listed]

Prescrire Int. 2003 Jun;12(65):85-8.

PMID:
12825569
4.

Neuraminidase inhibitors in patients with underlying airways disease.

Williamson JC, Pegram PS.

Am J Respir Med. 2002;1(2):85-90. Review.

PMID:
14720062
5.

Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.

Wutzler P, Kossow KD, Lode H, Ruf BR, Scholz H, Vogel GE; Expert Group, German Association for the Control of Virus Diseases and Paul-Ehrlich Society of Germany.

J Clin Virol. 2004 Oct;31(2):84-91.

PMID:
15364262
6.

Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.

Rothberg MB, Bellantonio S, Rose DN.

Ann Intern Med. 2003 Sep 2;139(5 Pt 1):321-9.

PMID:
12965940
7.

Prevention and early treatment of influenza in healthy adults.

Demicheli V, Jefferson T, Rivetti D, Deeks J.

Vaccine. 2000 Jan 6;18(11-12):957-1030. Review.

PMID:
10590322
8.

Neuraminidase inhibitors for preventing and treating influenza in children.

Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A.

Cochrane Database Syst Rev. 2003;(3):CD002744. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD002744.

PMID:
12917931
9.

Neuraminidase inhibitors for preventing and treating influenza in children.

Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD002744. doi: 10.1002/14651858.CD002744.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD002744.

PMID:
22258949
10.
11.

Antiviral therapy of influenza.

Englund JA.

Semin Pediatr Infect Dis. 2002 Apr;13(2):120-8. Review.

PMID:
12122950
12.

Cost-effectiveness of newer treatment strategies for influenza.

Smith KJ, Roberts MS.

Am J Med. 2002 Sep;113(4):300-7.

PMID:
12361816
13.

Spotlight on zanamivir in influenza.

Cheer SM, Wagstaff AJ.

Am J Respir Med. 2002;1(2):147-52. Review.

PMID:
14720068
14.
15.

[Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination].

Uhnoo I, Linde A.

Lakartidningen. 2005 Dec 5-11;102(49):3802-3, 3805-6, 3808. Review. Swedish.

PMID:
16408704
16.

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K.

Health Technol Assess. 2003;7(35):iii-iv, xi-xiii, 1-170. Review.

17.
18.

[Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].

de Jong JC, Beyer WE, Rimmelzwaan GF, Fouchier RA, Osterhaus AD.

Ned Tijdschr Geneeskd. 2004 Jan 10;148(2):73-9. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2004 Feb 14;148(7):348.

PMID:
14753128
19.

Updated treatment for influenza A and B.

Montalto NJ, Gum KD, Ashley JV.

Am Fam Physician. 2000 Dec 1;62(11):2467-76. Review.

20.

Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza.

Dreitlein WB, Maratos J, Brocavich J.

Clin Ther. 2001 Mar;23(3):327-55. Review.

PMID:
11318072

Supplemental Content

Support Center